Oncology
 |
|
11 december 2019 07:02:49 |
| Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer (Future Oncology) |
|
Tweet Future Oncology, Ahead of Print. |
| 220 viewsCategory: Oncology |
 Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysis (Future Oncology)p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53 (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
